Teenager Keiran Halliday grows 8 inches in a YEAR after brain tumour
Keiran Halliday, 19, from Bridgend, South Wales, has shot up eight inches in the last year after he was diagnosed with acromegaly, where the body produces too much growth hormone. (Source: the Mail online | Health)
Source: the Mail online | Health - October 15, 2014 Category: Consumer Health News Source Type: news
Ghrelin paralleled adiposity increase after acromegaly surgery
The rise in total ghrelin found to accompany some remaining cardiovascular risk markers and adiposity increase in patients with acromegaly remission after surgery could be interrelated, according to research published in The Journal of Clinical Endocrinology & Metabolism. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 15, 2014 Category: Endocrinology Source Type: news
Understanding Acromegaly Medications
Acromegaly Medications (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 15, 2014 Category: Journals (General) Source Type: news
Acromegaly FAQs
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 28, 2014 Category: Journals (General) Source Type: news
Hustle and bustle at ICE/ENDO 2014
I arrived at McCormick Place to find all the usual hustle and bustle associated with ENDO. I queued, picked up my chic (!) backpack and rushed off to hang my poster. I also had a chance to take a peak at the history of endocrinology timeline as the Endocrine Society approaches it's centenary.
ENDO2014 was officially kicked off yesterday by Robert Lefkowitz who gave us an insightful tour through his lifetime's research on seven transmembrane receptors. His more recent discoveries on B-arrestins were fascinating. I bumped into Sam Mirczuk, Chair of the YE committee in this session :)
John Newell-P...
Source: Society for Endocrinology - July 2, 2014 Category: Endocrinology Source Type: news
'I'm the real life Jaws': Student, 36, has condition which means his jaw bone won't stop growing
Richard Moore, from Wigan, has acromegaly - meaning some of his bones continue to increase in size after the skeleton and other organs have finished growing. (Source: the Mail online | Health)
Source: the Mail online | Health - June 20, 2014 Category: Consumer Health News Source Type: news
2014 ASPIRE Young Investigator Research Awards in Endocrinology
The mission of the 2014 ASPIRE Young Investigator Research Awards in Endocrinology is to advance the medical knowledge of the fundamental mechanisms of disease, mechanisms of action of current and potential future treatments, and to improve the care of patients with endocrine disorders.
Funding will be provided to research proposals that seek to explore basic, translational, or clinical research in the area of endocrine disease in adults and children:
Clinical and Translational Research in the GH and IGF-I Axis
Morbidity and Mortality in Patients with Acromegaly
Novel measures of growth hormone treatment benefits
S...
Source: Society for Endocrinology - May 21, 2014 Category: Endocrinology Source Type: news
Pasireotide LAR for Acromegaly but Hyperglycemia a DrawbackPasireotide LAR for Acromegaly but Hyperglycemia a Drawback
Pasireotide LAR improves response in acromegaly patients poorly controlled on first-generation somatostatins, but hyperglycemia remains an issue as the agent awaits regulatory approval for this indication. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 15, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
New Funding for Clinical Endocrinology Quality Improvement Projects available from the Clinical Endocrinology Trust
The Clinical Endocrinology Trust has long supported Endocrine Audit projects within the UK. Recent examples include the UK Acromegaly Database, the CaHASE audit of adults with CAH, and a BTA study of teenage iodine status across the UK.
The Trustees now invite further applications from Societies or Endocrine Centres within the UK. Preference will be given to projects involving multicentre collaborations. We are particularly interested in receiving applications related to areas of endocrinology the Trust has not supported previously. A total sum of £50,000 is avail...
Source: Society for Endocrinology - April 25, 2014 Category: Endocrinology Source Type: news
Acromegaly, IGF1 bioactivity, and S-Klotho
The value of measuring IGF1 bioactivity in active acromegaly is unknown. Soluble Klotho (S-Klotho) level is elevated in active acromegaly and it has been suggested that S-Klotho can inhibit activation of the IGF1 receptor (IGF1R). A cross-sectional study was carried out in 15 patients with active acromegaly, finding that IGF1 bioactivity was within the reference range in a considerable number of subjects with active acromegaly and that elevated S-Klotho levels may have reduced IGF1 bioactivity. Moreover, IGF1 bioactivity was more strongly related to physical measures of QoL than total IGF1, suggesting that IGF1 bioactivity...
Source: Society for Endocrinology - April 25, 2014 Category: Endocrinology Source Type: news
Sharing your patient record can help researchers save and improve lives
The Society for Endocrinology is supporting a new campaign to raise awareness about the importance of sharing data from patient records with researchers. By allowing researchers access to the information contained within our records, we can contribute towards understanding the causes of disease and develop new and better medicines.
Access to health data has played a major role in the Society's own project, such as the UK Acromegaly Register. This project, initially set up in 1997, collects prospective and retrospective data on patients with acromegaly to assess outcomes of surgery, radiotherapy and medica...
Source: Society for Endocrinology - January 14, 2014 Category: Endocrinology Source Type: news
New research on sauropod gigantism summarized in publicly available collection
(Johannes Gutenberg Universitaet Mainz) Dr. Eva Maria Griebeler of Johannes Gutenberg University Mainz has now shown that the hypothesis is inaccurate that their body size was limited only because the associated rise in body temperature could have resulted in potential overheating. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 14, 2014 Category: Biology Source Type: news
Growth Disorder Tx Has Room for Improvement (CME/CE)
(MedPage Today) -- Although control of the disease has improved over the past few decades, about a quarter of patients with acromegaly aren't hitting treatment targets, British researchers found. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - October 11, 2013 Category: Pediatrics Source Type: news
UK Acromegaly Register: drugs fail to meet hormone targets in control of rare growth disorder
A study by the Society for Endocrinology UK Acromegaly Register published in Clinical Endocrinology assesses medical treatment of acromegaly in routine clinical practice over 30 years.
Full article
Clinical Endocrinology is the Society for Endocrinology's official clinical journal. (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 10, 2013 Category: Endocrinology Source Type: news
A bigger fish for palaeontogists to fry…
A chance find in a quarry led to the discovery that Leedsichthys problematicus grew up to 50ft long – double previous estimatesAn international team of scientists has uncovered the remains of the world's largest fish. The 50ft Leedsichthys problematicus swam the oceans of the Jurassic era more than 160m years ago, sweeping up shoals of plankton through giant, mesh-covered gills. Leedsichthys was eventually wiped out by the same catastrophe that killed the dinosaurs 66m years ago.The discovery by the team – led by Professor Jeff Liston of the National Museums of Scotland – is intriguing because it reveals that just as...
Source: Guardian Unlimited Science - August 24, 2013 Category: Science Authors: Robin McKie Tags: Evolution Dinosaurs Editorial The Observer Fossils Zoology Science Source Type: news
